title: [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
abstract: The case of a 54 year old patient suffering from a prostatic carcinoma is presented. At the time of diagnosis multiple bone metastases were detected by bone scintigraphy. An initial improvement was observed following antiandrogenic therapy. After three years the patient presented with increasing bone pain, which was most prominent in the knee joints. A "superscan" was found in bone scintigraphy with an unusually high uptake in the peripheral skeleton. Bone marrow scinitgraphy showed a nearly complete metastatic displacement of central bone marrow and a peripheral marrow extension as explanation for the bone scan findings.
authors.affiliation: Urologische Klinik, Heinrich-Heine-Universität Düsseldorf, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Weckesser
authors.forename: V G
authors.initials: VG
authors.lastname: Müller-Mattheis
authors.forename: H
authors.initials: H
authors.lastname: Vosberg
authors.forename: H W
authors.initials: HW
authors.lastname: Müller-Gärtner
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D001853:Bone Marrow / Q000000981:diagnostic imaging*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D003937:Diagnosis, Differential; D004164:Diphosphonates; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D015609:Organotechnetium Compounds; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy; D011859:Radiography; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
chemical_list: D000726:Androgen Antagonists; D004164:Diphosphonates; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C033905:technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid
vernacular_title: Pathogenetische Differenzierung des Skelettsuperscans mittels Knochenmarkszintigraphie.